Open AccessMaternal Serum Soluble Endoglin Levels as a biomarker in Preeclampsia: A Case Control Tertiary Care Hospital Based Study
Author(s) -
Krishnaveni Changalvala,
Kiranmayee Pamidimukkala,
Raghuveer. C. V,
S. R. Sheela,
Kalyani Raju,
Venkateshu K. V Venkateshu K. V
Publication year - 2022
Publication title -
biomedical and pharmacology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.191
H-Index - 18
eISSN - 2456-2610
pISSN - 0974-6242
DOI - 10.13005/bpj/2451
Subject(s) - medicine , preeclampsia , gestation , obstetrics and gynaecology , obstetrics , biomarker , pregnancy , case control study , tertiary care , gestational age , receiver operating characteristic , endoglin , informed consent , population , gynecology , pathology , biochemistry , chemistry , genetics , alternative medicine , stem cell , environmental health , cd34 , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom